![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/00 | |
A61K 47/54 | |||
C07K 14/50 | |||
A61K 38/18 |
(11) | Number of the document | 3236991 |
(13) | Kind of document | T |
(96) | European patent application number | 15817847.5 |
Date of filing the European patent application | 2015-12-22 | |
(97) | Date of publication of the European application | 2017-11-01 |
(45) | Date of publication and mention of the grant of the patent | 2019-06-19 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2015/080969 |
Date | 2015-12-22 |
(87) | Number | WO 2016/102562 |
Date | 2016-06-30 |
(30) | Number | Date | Country code |
14199935 | 2014-12-23 | EP |
(72) |
WIECZOREK, Birgit, DK
TAGMOSE, Tina M ller, DK
SASS- RUM, Kristian, DK
ANDERSEN, Birgitte, DK
OLSEN, J rgen, DK
|
(73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
(54) | FGF21 DERIVATIVES AND USES THEREOF |
FGF21 DERIVATIVES AND USES THEREOF |